BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34785162)

  • 1. Serotonin 1A receptor agonist modulation of motor deficits and cortical oscillations by NMDA receptor interaction in parkinsonian rats.
    Jiang X; Liang P; Wang K; Jia J; Wang X
    Neuropharmacology; 2022 Feb; 203():108881. PubMed ID: 34785162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat.
    Dupre KB; Eskow KL; Steiniger A; Klioueva A; Negron GE; Lormand L; Park JY; Bishop C
    Psychopharmacology (Berl); 2008 Jul; 199(1):99-108. PubMed ID: 18545986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease.
    Lindenbach D; Dupre KB; Eskow Jaunarajs KL; Ostock CY; Goldenberg AA; Bishop C
    Brain Res; 2013 Nov; 1537():327-39. PubMed ID: 24060645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease.
    Dupre KB; Cruz AV; McCoy AJ; Delaville C; Gerber CM; Eyring KW; Walters JR
    Neurobiol Dis; 2016 Feb; 86():1-15. PubMed ID: 26586558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of 5-HT₁A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease.
    Sun YN; Wang T; Wang Y; Han LN; Li LB; Zhang YM; Liu J
    Neuropharmacology; 2015 Aug; 95():181-91. PubMed ID: 25797491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the primary motor cortex in L-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation.
    Ostock CY; Dupre KB; Jaunarajs KL; Walters H; George J; Krolewski D; Walker PD; Bishop C
    Neuropharmacology; 2011 Sep; 61(4):753-60. PubMed ID: 21635907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action.
    Iderberg H; Rylander D; Bimpisidis Z; Cenci MA
    Exp Neurol; 2013 Dec; 250():116-24. PubMed ID: 24029003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats.
    Bishop C; Krolewski DM; Eskow KL; Barnum CJ; Dupre KB; Deak T; Walker PD
    J Neurosci Res; 2009 May; 87(7):1645-58. PubMed ID: 19115412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early decreases in cortical mid-gamma peaks coincide with the onset of motor deficits and precede exaggerated beta build-up in rat models for Parkinson's disease.
    Brazhnik E; Novikov N; McCoy AJ; Ilieva NM; Ghraib MW; Walters JR
    Neurobiol Dis; 2021 Jul; 155():105393. PubMed ID: 34000417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The theta-related firing activity of parvalbumin-positive neurons in the medial septum-diagonal band of Broca complex and their response to 5-HT1A receptor stimulation in a rat model of Parkinson's disease.
    Li LB; Han LN; Zhang QJ; Sun YN; Wang Y; Feng J; Zhang L; Wang T; Chen L; Liu J
    Hippocampus; 2014 Mar; 24(3):326-40. PubMed ID: 24174292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 5-HT
    Vegas-Suárez S; Aristieta A; Requejo C; Bengoetxea H; Lafuente JV; Miguelez C; Ugedo L
    Br J Pharmacol; 2021 Jun; 178(12):2516-2532. PubMed ID: 33686657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson's disease: role of NMDA vs. 5-HT1A receptors.
    Paquette MA; Martinez AA; Macheda T; Meshul CK; Johnson SW; Berger SP; Giuffrida A
    Eur J Neurosci; 2012 Nov; 36(9):3224-34. PubMed ID: 22861201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin
    Liu Y; Liu J; Jiao SR; Liu X; Guo Y; Zhang J; Yang J; Xie W; Wang HS; Zhang L
    Behav Brain Res; 2019 Dec; 376():112207. PubMed ID: 31476331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT
    Pinna A; Costa G; Serra M; Contu L; Morelli M
    Neuropharmacology; 2021 Sep; 196():108693. PubMed ID: 34229013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased response of interneurons in the medial prefrontal cortex to 5-HT₁A receptor activation in the rat 6-hydroxydopamine Parkinson model.
    Zhang Q; Wang S; Zhang L; Zhang H; Qiao H; Niu X; Liu J
    Neurol Sci; 2014 Aug; 35(8):1181-7. PubMed ID: 24563117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 5-HT1A receptor stimulation on D1 receptor agonist-induced striatonigral activity and dyskinesia in hemiparkinsonian rats.
    Dupre KB; Ostock CY; George JA; Eskow Jaunarajs KL; Hueston CM; Bishop C
    ACS Chem Neurosci; 2013 May; 4(5):747-60. PubMed ID: 23496922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selective 5-HT
    Fisher R; Hikima A; Morris R; Jackson MJ; Rose S; Varney MA; Depoortere R; Newman-Tancredi A
    Neuropharmacology; 2020 May; 167():107997. PubMed ID: 32057799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral lesion of the nigrostriatal pathway decreases the response of GABA interneurons in the dorsal raphe nucleus to 5-HT(1A) receptor stimulation in the rat.
    Hou C; Xue L; Feng J; Zhang L; Wang Y; Chen L; Wang T; Zhang QJ; Liu J
    Neurochem Int; 2012 Dec; 61(8):1344-56. PubMed ID: 23032407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the Dorsal Hippocampus 5-HT1A Receptors in the Regulation of Depressive-Like Behaviors in Hemiparkinsonian Rats.
    Jiang YF; Liu J; Yang J; Guo Y; Hu W; Zhang J; La XM; Xie W; Wang HS; Zhang L
    Neuropsychobiology; 2020; 79(3):198-207. PubMed ID: 31940619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dopamine D3 and serotonin 5-HT 1A receptors in L: -DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Gerlach M; Bartoszyk GD; Riederer P; Dean O; van den Buuse M
    J Neural Transm (Vienna); 2011 Dec; 118(12):1733-42. PubMed ID: 21253782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.